Page last updated: 2024-12-07

1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine (also known as **MPP+**) is a **potent neurotoxin** that is structurally similar to **MPTP**, a compound that causes Parkinson's disease-like symptoms in humans.

Here's why it's important for research:

* **Parkinson's Disease Research:** MPP+ is a key tool for understanding the pathogenesis of Parkinson's disease. It selectively targets and destroys **dopaminergic neurons** in the substantia nigra, a brain region crucial for movement control. This makes MPP+ a valuable tool for:
* Studying the mechanisms of neurotoxicity in Parkinson's disease
* Testing potential therapeutic agents for Parkinson's disease
* Developing models of Parkinson's disease in laboratory animals

* **Drug Development:** MPP+ is used in preclinical drug discovery to:
* **Identify compounds that protect against MPP+ toxicity**, potentially leading to new treatments for Parkinson's disease.
* **Test the effects of drugs on dopaminergic neurons**, aiding in the development of medications for other neurological disorders.

* **Neurobiology Research:** MPP+ is a valuable tool for studying:
* **Mitochondrial function** and its role in neuronal health
* **Cellular stress response mechanisms**
* **The effects of environmental toxins on the nervous system**

**It's important to note that MPP+ is highly toxic and should only be handled by trained professionals in a controlled laboratory setting.**

In summary, 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine (MPP+) plays a crucial role in Parkinson's disease research, drug development, and neurobiology research. Its ability to specifically target and damage dopaminergic neurons makes it a powerful tool for understanding and treating this debilitating neurological disorder.

Cross-References

ID SourceID
PubMed CID129529
CHEMBL ID292489
MeSH IDM0179675

Synonyms (7)

Synonym
CHEMBL292489
4-(2-ethylphenyl)-1-methyl-3,6-dihydro-2h-pyridine
107316-68-7
1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine
pyridine, 4-(2-ethylphenyl)-1,2,3,6-tetrahydro-1-methyl-
2'-et-mptp
DTXSID60148013

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The toxic effects of the tetrahydropyridines and their corresponding pyridiniums were both concentration- and time-dependent."( 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma, AN; Geller, HM; Giovanni, A; Heikkila, RE; Nicklas, WJ, 1990
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID235549Selectivity Coefficient measured as ratio of Vmax/Km value of MAO-B to that of MAO-A1997Journal of medicinal chemistry, Jun-20, Volume: 40, Issue:13
Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators.
AID127348Binding affinity towards monoaminooxidase Relative to MPTP1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID125694Tested for Kinetic data against the monoamine oxidase A catalyzed oxidation.1997Journal of medicinal chemistry, Jun-20, Volume: 40, Issue:13
Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators.
AID235548Selectivity Coefficient measured as ratio of Vmax/Km value of MAO-A to that of MAO-B1997Journal of medicinal chemistry, Jun-20, Volume: 40, Issue:13
Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators.
AID126526Tested for Kinetic data against the monoamine oxidase B catalyzed oxidation.1997Journal of medicinal chemistry, Jun-20, Volume: 40, Issue:13
Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]